secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2022-04-15T23:59:59+00:00
Accession:  0001628280-22-009372
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Chromadex director Caroline Levy resigns from board and committees
------------------------------------------------------------------

- Levy resigned effective April 11, 2022; no disagreement with the company cited.
- She also stepped down from the Audit Committee and Nominating and Corporate Governance Committee.
- No replacement or interim appointment announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000162828022009372/0001628280-22-009372-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000162828022009372/cdxc-20220411.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-009372

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer